Sanofi & Cipla partner to expand reach of CNS portfolio in India
India, March 26 -- Sanofi India and SanofiHealthcare India, and Cipla have announced an exclusive partnership for distribution andpromotion of Sanofi India's Central Nervous System(CNS) product range in India.
As a part of this partnership, Cipla will be responsible for thedistribution of Sanofi India's six CNS brands including Frisium, a leading brandin the anti-epileptic medication category.
WhileSanofi India will continue to own, import, and manufacture its complete range of CNS productsacross plants in India and internationally, Mumbai-based pharmaceutical company Cipla will leverage its capabilities androbust India-wide network of strong marketing and sales professionals, distributors, institutions, and market outreach programmesto...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.